FMP

FMP

Enter

ATXI - Avenue Therapeutics,...

photo-url-https://images.financialmodelingprep.com/symbol/ATXI.png

Avenue Therapeutics, Inc.

ATXI

NASDAQ

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.

1.86 USD

0.12 (6.45%)

Valuation Date:

Dec 26, 2024 4:00 PM

Share Price on Valuation Date

$1.86

Stock Beta

-0.179

Shares Outstanding

2053920

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep